Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-28 @ 11:02 AM
Study NCT ID:
NCT02126904
Status:
UNKNOWN
Last Update Posted:
2014-04-30
First Post:
2014-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
Sponsor:
Yokohama City University Medical Center
Organization:
Study Overview
Official Title:
Comparison of the Time to Recurrence After Ranibizumab or Aflibercept Loading for Age-related Macular Degeneration
Status:
UNKNOWN
Status Verified Date:
2014-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators compared the time to recurrence after ranibizumab or aflibercept loading in patients with AMD.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: